The role of quantitative tumor burden based on [ 68 Ga]Ga-DOTA-NOC PET/CT in well-differentiated neuroendocrine tumors: beyond prognosis.
Luohai ChenNuerailaguli JumaiQiao HeMan LiuYuan LinYanji LuoYu WangMin-Hu ChenZhirong ZengXiangsong ZhangNing ZhangPublished in: European journal of nuclear medicine and molecular imaging (2022)
Ga]Ga-DOTA-NOC PET/CT was correlated with OS and PFS in patients with non-functional NETs with a ki-67 index of ≤ 10% who received octreotide LAR. Calculating normalized and liver normalized doses may help in selecting the starting dose of octreotide LAR.